Bicycle Therapeutics plc Working Capital to Net Assets Ratio
Bicycle Therapeutics plc working capital to net assets ratio. Bicycle Therapeutics plc (50BA) has a Working Capital to Net Assets ratio of 103.4% as of June 2026. Working capital of €527.60 Million (current assets of €575.24 Million minus current liabilities of €47.63 Million) is measured against net assets of €510.25 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 50BA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Bicycle Therapeutics plc (2018–2025)
Working capital to net assets ratio of Bicycle Therapeutics plc from 2018 to 2025. This chart shows how Bicycle Therapeutics plc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 103.4%, reflecting working capital of €527.60 Million against net assets of €510.25 Million EUR. See 50BA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Bicycle Therapeutics plc Working Capital to Net Assets Ratio by Year (2018–2025)
Bicycle Therapeutics plc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Bicycle Therapeutics plc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Bicycle Therapeutics plc assets under control.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 102.6% | €625.90 Million | €609.98 Million | €682.88 Million | €56.98 Million | ▼ -6.0 pp |
| 2024 | 108.6% | €861.38 Million | €793.06 Million | €928.61 Million | €67.23 Million | ▼ -24.1 pp |
| 2023 | 132.7% | €492.33 Million | €370.93 Million | €561.87 Million | €69.54 Million | ▲ +16.0 pp |
| 2022 | 116.7% | €316.04 Million | €270.78 Million | €369.38 Million | €53.34 Million | ▼ -5.3 pp |
| 2021 | 122.0% | €422.32 Million | €346.25 Million | €458.56 Million | €36.24 Million | ▼ -16.9 pp |
| 2020 | 138.9% | €132.59 Million | €95.46 Million | €155.72 Million | €23.13 Million | ▲ +36.6 pp |
| 2019 | 102.3% | €95.33 Million | €93.20 Million | €104.15 Million | €8.82 Million | ▲ +199.4 pp |
| 2018 | -97.2% | €67.84 Million | €-69.83 Million | €76.77 Million | €8.93 Million | — |